|
Volumn 19, Issue 17-19, 2001, Pages 2323-2328
|
Peptide and recombinant antigens for protection against bacterial middle ear infection
|
Author keywords
Adhesin; Chinchilla; Nontypeable Haemophilus influenzae
|
Indexed keywords
ADHESIN;
ANTISERUM;
BACTERIAL ANTIGEN;
HAEMOPHILUS INFLUENZAE ANTISERUM;
HAEMOPHILUS VACCINE;
HYBRID PROTEIN;
LB1 ANTIGEN;
LIPOPROTEIN D LB1 (F) FUSION PROTEIN;
PROTEIN P5 FIMBRIN;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BACTERIUM ISOLATE;
CHINCHILLA;
CLINICAL FEATURE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFICACY;
EAR PROTECTION;
ERADICATION THERAPY;
HAEMOPHILUS INFLUENZAE;
MORBIDITY;
NASOPHARYNX;
NONHUMAN;
OTITIS MEDIA;
PASSIVE IMMUNIZATION;
PRIORITY JOURNAL;
ANIMALS;
ANTIBODIES, BACTERIAL;
ANTIGENS, BACTERIAL;
CHINCHILLA;
HAEMOPHILUS INFECTIONS;
HAEMOPHILUS INFLUENZAE;
HAEMOPHILUS VACCINES;
HUMANS;
IMMUNIZATION, PASSIVE;
NASOPHARYNX;
OTITIS MEDIA;
PEPTIDES;
RECOMBINANT PROTEINS;
|
EID: 0035925683
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(00)00522-3 Document Type: Conference Paper |
Times cited : (14)
|
References (19)
|